Advanced CAR-T Leukemia Therapy in Israel

Sheba’s Hemato-Oncology Department is one of only a few medical facilities in the world to offer this revolutionary treatment for blood cancer. CAR-T cell therapy programs the patient’s own altered white blood cells to kill cancer cells. It has led to many positive outcomes, putting cancer into remission in many patients who did not respond to other treatment methods. CAR-T cell therapy is highly specialized and personalized to consider each individual’s unique needs and overall well-being.

Who Can Have CAR-T Treatment?

Potential patients need to have undergone at least two prior treatments. The CAR-T protocol requires hospitalization for at least two weeks, but same patients may need a longer observation period.
Great success has been achieved in young patients with CAR-T treatment. The following are the rates of complete recovery with this therapy:

  • 85-90% in young children
  • Approximately 80% in teenagers
  • Around 70% in the entire patient population

Of course, Sheba continues to strive to further improve these rates through continuous research and retaining the best physicians.

Sheba is excited to announce that it now offers the innovative CAR T-cell therapy for patients with Multiple Myeloma and is the first medical center in the world to pioneer its application for Acute Myelogenous Leukemia (AML) with 8:21 translocation and CD19 expression as part of a clinical study.

We also offer a full diagnostic procedure to determine whether this treatment is a suitable option for a patient.

Why Come to Sheba for

CAR-T Therapy?

There are only a handful of medical facilities in the world that provide CAR-T therapy. There are many benefits to selecting Sheba Medical Center for your treatment. Here are a few:

Convenient
on-site care

We feature full CAR-T facilities under one-roof (including cell harvesting, chemotherapy, genetic engineering laboratory, T-cell injections, and patient observation), creating an efficient experience.

Full
accreditation

We are fully accredited for international healthcare by the Joint Commission International (JCI)

Affordable
fees

Medical expenses are generally lower than in the US, and we offer full transparency with no hidden costs

Patient-
friendly

A coordinator from the International Medical Tourism Division will assist with everything from travel to translation

World-renowned
specialists

Our staff includes some of the most qualified and experienced oncologists, hematologists, and immunologists in the world

Holistic
care

Healthcare at Sheba is provided with a holistic approach; treatments are designed to take the patient’s quality of life and overall well-being into consideration

Time is of the essence
with a disease like leukemia

Use this official Sheba website to contact us now and schedule a free consultation

schedule a free consultation

Sheba – Ranked in the

Top Ten Best Hospitals Worldwide

Sheba Medical Center sets the standard for excellence in patient-focused care. Recently, Newsweek included Sheba on their prestigious list of the Top Ten Best Hospitals Worldwide. This endorsement recognizes Sheba as a leading force in medical science and biotechnological innovation – maximizing the latest technologies while always providing holistic, outstanding healthcare. Sheba is strongly committed to delivering personalized, expert medicine to everyone from all over the world.

The 10 Best Hospitals in the World

Meet the Director

Arnon Nagler, MD

Arnon Nagler, MD

Director of the Division of Hematology Director of Bone Marrow Transplantation and Cord Blood Bank

Prof. Nagler specializes in hematology, bone marrow transplantation, and internal medicine. He has pioneered numerous treatments for malignant and non-malignant blood disorders in Israel. He established the first public cord blood bank at Sheba in 2001, and he performed the first cord blood transplantation in Israel. In addition to his role at Sheba Medical Center, Prof. Nagler is a Professor of Medicine at Tel-Aviv University.
Prof. Nagler received his medical degree from the Hebrew University – Hadassah Medical School, in Jerusalem, Israel, and then completed a postdoctoral fellowship at Stanford University, in the United States. In addition to receiving numerous awards, he is widely published and a world-renowned speaker. Prof. Nagler has also been the lead investigator on over 15 clinical trials and holds over 40 patents and trademarks. He is a member of the EHA Scientific Program Committee, and Chair of the European Leukemia Subcommittee on Transplantation.

Holistic Healing at Sheba

Our holistic approach to healthcare means that all Sheba patients benefit from world-class medicine provided with a personal touch. When designing your treatment program in Israel, we pay attention to more than just the disease – considering all aspects of well-being, including your physical, emotional, and social needs. As the largest hospital in the region, we provide every service you need conveniently under one roof on our vast campus. Every patient is also assigned a personal medical coordinator from the International Medical Tourism Division, who will provide assistance throughout every step of your treatment.

Sheba Medical Center

Tailor-made medicine

Patients need specialized, progressive therapies and compassionate care for the treatment of hematological disorders. To learn more about our expert services and book a consultation at Sheba Medical Center
Fill in the form below or call as at +972-77-9966905

Request a consultation

Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.

We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.

Request a consultation and a Sheba Case Manager will contact you shortly:

Request a consultation